KDR and neoplasm: Chinnasamy et al. demonstrated that the antitumor effect of VEGFR-2 targeting CAR- T cells was not mediated through their direct cytotoxicity on the tumor cells but rather through their ability to eliminate VEGFR-2-expressing cells in the tumor vasculature.